MARKET

TRIB

TRIB

Trinity Biotech Plc
NASDAQ
2.040
+0.060
+3.03%
Closed 16:00 03/28 EDT
OPEN
2.010
PREV CLOSE
1.980
HIGH
2.040
LOW
1.960
VOLUME
18.21K
TURNOVER
0
52 WEEK HIGH
6.20
52 WEEK LOW
1.850
MARKET CAP
15.59M
P/E (TTM)
-0.1042
1D
5D
1M
3M
1Y
5Y
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
Trinity Biotech plc will report financial results for the fourth quarter and fiscal year 2023 on April 4, 2024 at 8:00am ET. Trinity Biotech is a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets.
Barchart · 21h ago
Weekly Report: what happened at TRIB last week (0318-0322)?
Weekly Report · 4d ago
Weekly Report: what happened at TRIB last week (0311-0315)?
Weekly Report · 03/18 09:29
Weekly Report: what happened at TRIB last week (0304-0308)?
Weekly Report · 03/11 09:28
Weekly Report: what happened at TRIB last week (0226-0301)?
Weekly Report · 03/04 09:29
Investors Don't See Light At End Of Trinity Biotech plc's (NASDAQ:TRIB) Tunnel And Push Stock Down 27%
Trinity Biotech plc's share price has dropped 27% in the last month. The company's price-to-sales ratio of 0.3x is lower than the Medical Equipment industry average. Trinity Biotech's shrinking revenue over the medium-term is contributing to its low P/S ratio. The share price may look like a strong buying opportunity at present.
Simply Wall St · 03/02 12:08
Weekly Report: what happened at TRIB last week (0219-0223)?
Weekly Report · 02/26 09:31
Weekly Report: what happened at TRIB last week (0212-0216)?
Weekly Report · 02/19 09:32
More
About TRIB
Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.

Webull offers Trinity Biotech plc (ADR) stock information, including NASDAQ: TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.